Redefining Tissue Resection for BPH

Familiar workflow. Greater efficiency.

Resectus Medical is developing a new approach to transurethral resection for BPH. Our flagship technology is designed to enable more efficient removal of obstructive prostate tissue while building on the established TURP procedure.

The Problem

Benign Prostatic Hyperplasia (BPH)

BPH is a non-cancerous enlargement of the prostate that can obstruct urinary flow as it compresses the urethra. For patients, something as routine as urination can progressively become a daily burden.

Illustration showing benign prostatic hyperplasia and compression of the urethra

Bladder

Enlarged prostate

Urethra
(compressed)

The Clinical Burden

BPH becomes increasingly common with age.

90%

of men in their 80s are affected by BPH

50%

of men in their 60s are affected by BPH

Older man speaking with a healthcare professional

U.S. Burden 8M+ physician visits each year associated with BPH and related urinary symptoms Source: NIDDK, 2016

Frequency Urinating more often

Urgency A sudden need to urinate

Nocturia Waking at night to urinate

Difficulty Emptying Incomplete bladder emptying

90M+

men worldwide are living with BPH

Sources: Life Science Intelligence, 2025 & 2026.

THE ESTABLISHED STANDARD

Transurethral Resection of the Prostate

A FAMILIAR SURGICAL APPROACH

Effective. Durable. Familiar.

TURP removes obstructive prostate tissue through the urethra using a resectoscope and electrosurgical loop.

Its established workflow and durable outcomes have made it a longstanding standard in the surgical treatment of BPH.

0 . 0 M

BPH procedures performed annually worldwide

TURP remains the most commonly performed surgical procedure for BPH globally.

As prostate size increases,
so does the resection burden.

Larger glands require more tissue removal, extending the demands placed on an established resection workflow.

50–80 g

Moderate Enlargement

Illustration of moderate prostate enlargement

>80 g

Large Enlargement

Illustration of large prostate enlargement

Tissue volume

Resection time

Technical difficulty

Where the established workflow is challenged.

Bleeding and
Visualization

Bleeding can impair visualization and make it more difficult to maintain a clear operative field.

Time-Consuming
Procedure

Larger prostates can require longer resection times, greater surgeon effort, and greater procedural resources.

Technical
Demand

Anatomical constraints of rigid resectoscope systems can make resection more difficult in larger glands.

Technology

Enhanced Prostatic Resection (EPR)

Rethinking the geometry of resection.

BIPOLAR TURP

EPR

Greater Tissue Engagement

Anatomy-aligned resection

Improved Visualization

Maintaining the operative field during resection

Broader Treatment Applicability

Across a wider range of prostate sizes

Existing Infrastructure

Compatible with bipolar generators and reusable optics

Greater tissue
engagement

Improved
visualization

Broader treatment
applicability

Existing
infrastructure

Built by a team spanning urology, engineering, and commercialization.

Alexander Tinana, B.S.

Co-Founder & CEO

Teja Maruvada, M.S.E.

Co-Founder & CTO

Seth Jayawardane, B.S.

Co-Founder & Chief Design Engineer

E. James Wright, M.D.

Co-Founder & Clinical Lead

Recent News

Resectus Medical Pava Center MedTech Award

$10K

MAY 2025

Pava Center MedTech Award

Resectus Medical received a $10,000 MedTech Award through the Johns Hopkins Pava Marie LaPere Center for Entrepreneurship’s Innovation & Entrepreneurship Challenge, providing early non-dilutive support for technology and venture development.

IT’S OFFICIAL

JUL 2026

Resectus Medical Incorporates

Resectus Medical, Inc. was officially incorporated in July 2026, marking the beginning of our journey as a medical device company translating urologic innovation from research toward clinical impact.

Resectus Medical at the 2026 AUA Innovation Nexus Boot Camp

1 of 28

SEP 2026

AUA Innovation Nexus Boot Camp

Resectus Medical was selected as one of 28 companies to participate in the 2026 American Urological Association Innovation Nexus Boot Camp, a program providing focused mentorship for early-stage urology innovators.

View on LinkedIn →